Literature DB >> 10705655

Constitutive expression of cyclooxygenase-2 (COX-2) in developing brain. A. Choroid plexus in human fetuses.

D Maślińska1, A Kaliszek, J Opertowska, J Toborowicz, K Deregowski, D Szukiewicz.   

Abstract

It is believed that prostanoids produced by COX-1 activity are essential for the physiological functions of tissues while those produced by COX-2 lead to various pathological changes in these tissues. Brain is an exceptional organ where in some neurons COX-2 mRNA and its protein are constitutively expressed. Since some prostaglandins may play an important role in the control of blood-brain barrier and cerebral blood flow the purpose of the present study was to examine the COX-2 expression in choroid plexus, which participate in the nutrition of brain parenchyma of human fetuses. Study was performed on 25 brains of human fetuses from 12 to 38 weeks of gestation. In light and electron microscopy characteristic developmental transformation of choroid morphology was observed. In young fetuses from 12 to 20 week of gestation epithelial cells of choroid plexus are cuboidal, contain large amount of glycogen storage and their nuclei are COX-2 immunopositive. From 25 week of gestation until term the amount of glycogen in the choroid plexus diminishes, some apical nuclei are shifted toward central parts of the cells and number of cytoplasm organelles increases. In these cells expression of COX-2 protein is located in cytoplasm but epithelial nuclei are immunonegative. Our results provided evidence that COX-2 is constitutively expressed in the developing human choroid plexus. Different localization of COX-2 in choroid epithelial cells suggests that this enzyme may play a different role in various periods of the choroid plexus development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10705655

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  9 in total

Review 1.  Rationally designed multitarget agents against inflammation and pain.

Authors:  S H Hwang; A T Wecksler; K Wagner; B D Hammock
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

2.  Interleukin-1β, cyclooxygenase-2, and hypoxia-inducible factor-1α in asthenozoospermia.

Authors:  Eleonora Salvolini; Eddi Buldreghini; Guendalina Lucarini; Arianna Vignini; Alessia Giulietti; Andrea Lenzi; Laura Mazzanti; Roberto Di Primio; Giancarlo Balercia
Journal:  Histochem Cell Biol       Date:  2014-07-01       Impact factor: 4.304

3.  Expression of cyclooxygenase-1 (COX-1) and COX-2 in human male gametes from normal patients, and those with varicocele and diabetes: a potential molecular marker for diagnosing male infertility disorders.

Authors:  I Perrotta; M Santoro; C Guido; P Avena; S Tripepi; F De Amicis; M C Gervasi; S Aquila
Journal:  J Anat       Date:  2012-07-02       Impact factor: 2.610

Review 4.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 5.  Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs.

Authors:  J Martel-Pelletier; D Lajeunesse; P Reboul; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

6.  Prostaglandin E2 Increases Neurite Length and the Formation of Axonal Loops, and Regulates Cone Turning in Differentiating NE4C Cells Via PKA.

Authors:  Ashby Kissoondoyal; Dorota A Crawford
Journal:  Cell Mol Neurobiol       Date:  2021-01-03       Impact factor: 5.046

7.  The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis.

Authors:  Ruoshuang Zhang; Zheli Liu; Han Zhang; Yi Zhang; Dong Lin
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

8.  Synthesis, Characterization, and Biodistribution of Quantum Dot-Celecoxib Conjugate in Mouse Paw Edema Model.

Authors:  Suresh K Kalangi; Nitin K Swarnakar; R Sathyavathi; D Narayana Rao; Sanyog Jain; Pallu Reddanna
Journal:  Oxid Med Cell Longev       Date:  2018-03-22       Impact factor: 6.543

9.  Non-inflammatory Physiology of "Inflammatory" Mediators - Unalamation, a New Paradigm.

Authors:  Krishna Rao Maddipati
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.